Conversely, the chronic suppression of DGAT2 expression using a DGAT2-specific antisense oligonucleotide (ASO) has been associated with increased levels of ALT, a marker of hepatic inflammation, in mice with diet-induced hepatic steatosis [39]. This evidence concerns the gene DGAT2 and fatty liver disease.